α-Syn PFF treatment significantly up-regulated the ApoE protein (Fig. 3D), whose ε4 genotype in humans regulates α-syn pathology (21) and is associated with an increased risk of dementia in PD (22, 23) and AD (24). Here, APOE is linked to Parkinson disease.